Piramal Enterprises

BSE : 500302 | NSE : PEL

Industry : Pharmaceuticals | ISIN : INE140A01024 | FreeFloat : 50.00% | FnO : Yes | LotSize : 309


Intellectual Capital (IC)-827.73
Net Worth (NW)30,571.59
Intrinsic Worth (IW)29,743.86
Market Cap (MC)18,710.38
Economic Value Added-2,514.81
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-2.78%
IC Gross Margin (EBITDA/IC)-862.80%
IC Net Margin (NPT/IC)-99.18%
Knowledge Turnover (Sales/IC)-16.49
Market to Intrinsic Value (MC/IW)0.63

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 1,493.52Rs. 939.50
26 May 2020 - Rs. 906.25
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 900.73ReduceSell
KB > 50% : No50 DMA : Rs. 895.61
0 < M2IV < 1 : YesVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
C
2254.07
2337.91
1145.65
1022.74
349.51
247.46
128.67
Sep-17
C
2535.86
2611.25
1345.28
1215.95
491.24
301.49
353.45
Dec-17
C
2858.36
2922.15
1511.17
1401.18
651.46
439.67
1374.89
Mar-18
C
2991.06
3027.57
1417.30
1302.20
471.56
3851.57
3949.09
Jun-18
C
2902.49
2916.92
1541.10
1412.31
503.23
-130.04
-298.74
Sep-18
C
3144.10
3200.41
1709.35
1585.99
569.81
407.03
168.82
Dec-18
C
3489.08
3591.88
2130.08
1997.51
828.68
535.64
552.16
Mar-19
C
3679.67
3764.90
2027.87
1892.44
575.79
338.11
690.49
Jun-19
C
3506.25
3573.15
2234.29
2076.08
667.59
450.03
-394.92
Sep-19
C
3603.56
3666.24
2316.55
2150.16
731.95
554.08
466.76
Dec-19
C
3805.67
3947.00
2562.97
2396.53
954.80
724.19
866.28
Mar-20
C
3341.00
3580.55
336.65
193.74
-1101.53
-1702.59
-1865.65
* C - Consolidated, S - Standalone